1st Quarter - Report
INNOVATIVE FEDERAL STRATEGIES, LLC for ADURO BIOTECH
Client
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. ____ / S. ____ Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| CARL KIME | — |
| KALI MATALON | — |
| LETITIA WHITE | — |
Government Issues GOV
Contacted Members of Congress to provide information on recent clinical trials, cooperative vaccine research and development agreements with the University of California, and neglected tropical diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| CARL KIME New | — |
| KALI MATALON | — |
| LETITIA WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.